Within the GBM microenvironment, CXCR4 facilitates the immunosuppressive and therapy-resistant phenotype of GBM by regulating SDF-1α (CXCL12)-mediated CD11b+ myeloid cell migration [70]. This evidence concerns the gene CXCL12 and glioblastoma.